RIL shares in focus on $12 billion oil deal with Russia’s Rosneft

Reliance Industries secured a massive deal with Rosneft. The deal involves importing Russian crude oil. The agreement spans 10 years. Reliance will receive up to 500,000 barrels of oil daily. This equates to 25 million tonnes annually. The deal is estimated at $12-13 billion. India’s Russian oil imports have significantly increased. Reliance’s Jamnagar refineries will process the crude.

Cipla shares in focus after receiving CDSCO nod to launch inhalation insulin

Cipla has secured exclusive rights to distribute and market Afrezza, an inhalable insulin, in India. Developed by MannKind, Afrezza offers a non-injectable alternative for managing type 1 and type 2 diabetes. Clinical trials in India demonstrated its effectiveness in reducing HbA1c levels. Cipla aims to improve diabetes management accessibility with this innovative treatment.

Market to consolidate for another month, prioritise quality over momentum & value: Sunil Subramaniam

Market expert Sunil Subramaniam analyzes current market trends, citing low consumer spending, government underspending, and FII selling. He anticipates a market consolidation phase for another month, advising investors to prioritize quality stocks and remain patient. Subramaniam predicts increased government spending, improved earnings, and renewed FII interest by mid-January, driven by upcoming elections and budget expectations.